Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis

INTRODUCTION: Janus kinase (JAK) inhibitors are a class of targeted therapies for rheumatoid arthritis (RA) with established clinical efficacy. However, little is known about their efficacy compared with each other. This network meta-analysis (NMA) estimated the comparative efficacy of JAK inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Janet, Sawant, Ruta, Tundia, Namita, Du, Ella X., Qi, Cynthia Z., Song, Yan, Tang, Patrick, Betts, Keith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467453/
https://www.ncbi.nlm.nih.gov/pubmed/32297280
http://dx.doi.org/10.1007/s12325-020-01303-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467453/
https://www.ncbi.nlm.nih.gov/pubmed/32297280
http://dx.doi.org/10.1007/s12325-020-01303-3

Ejemplares similares